✦ LIBER ✦

Neoadjuvant chemotherapy with gemcitabine and S1 in patients with resectable and borderline resectable pancreatic cancer – A pilot study

✍ Scribed by Matsushita, Akira; Nakamura, Yoshiharu; Sumiyoshi, Hiroki; Aimoto, Takayuki; Yokoyama, Tadashi; Matsuda, Yoko; Ishiwata, Toshiyuki; Naito, Zenya; Uchida, Eiji

Book ID: 122137310
Publisher: S. Karger AG
Year: 2013
Tongue: English
Weight: 42 KB
Volume: 13
Category: Article
ISSN: 1424-3903
DOI: 10.1016/j.pan.2013.07.167

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine based neoadjuvant chemoradio

Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer

✍ Cho, In Rae; Chung, Moon Jae; Bang, Seungmin; Park, Seung Woo; Chung, Jae Bock; 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 362 KB

Neoadjuvant chemoradiotherapy with S-1 i

Neoadjuvant chemoradiotherapy with S-1 in patients with borderline resectable pancreatic cancer

✍ Shimizu, Dai; Fujii, Tsutomu; Hattori, Masashi; Suenaga, Masaya; Yamada, Suguru; 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 50 KB

Neoadjuvant Chemoradiation With Intensit

Neoadjuvant Chemoradiation With Intensity Modulated Radiation Therapy in Resectable and Borderline Resectable Pancreatic Cancer (PCa)

✍ Kharofa, J.R.; Kelly, T.; Wood, C.; George, B.; Tsai, S.; Ritch, P.; Wiebe, L.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Neoadjuvant chemoradiotherapy with S-1 i

Neoadjuvant chemoradiotherapy with S-1 in patients with borderline resectable pancreatic cancer with involvement of the major artery

✍ Suenaga, M.; Fujii, T.; Yamada, S.; Okumura, N.; Kobayashi, D.; Tanaka, C.; Naka 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 46 KB

Maximizing the Effect of Neoadjuvant Che

Maximizing the Effect of Neoadjuvant Chemoradiation in Patients with Borderline Resectable Pancreatic Cancer

✍ D.M. Sopka; Y.S. Chun; S.J. Cohen; F. Zhu; B.N. Milestone; H.S. Cooper; G.M. Fre 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Neoadjuvant Chemotherapy with Gemcitabin

Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial

✍ Fuyuhiko Motoi MD, Kazuyuki Ishida MD, Fumiyoshi Fujishima MD, Shigeru Ottomo MD 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 342 KB